XML 20 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Financial Instruments
3 Months Ended
Mar. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
The fair values of the Company’s financial instruments are recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The three levels are described below:
Level 1 - Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.
Level 2 - Inputs other than Level 1 that are directly or indirectly observable, such as quoted prices for similar assets or liabilities and quoted prices in less active markets.
Level 3 - Inputs are unobservable for the asset or liability and are developed based on the best information available in the circumstances, which might include the Company’s own data.
The following summarizes the valuation of the Company’s financial instruments (in thousands). The tables do not include either cash on hand or assets and liabilities that are measured at historical cost or any basis other than fair value.
Fair Value Measurements
at March 30, 2024 Using
DescriptionQuoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable
Inputs
(Level 2)
Total
Cash equivalents:
Money market funds$107,746 $— $107,746 
Total cash equivalents$107,746 $— $107,746 
Short-term investments:
Corporate debt securities$— $58,743 $58,743 
Government debt securities— 82,458 82,458 
Total short-term investments$— $141,201 $141,201 
Total$107,746 $141,201 $248,947 
Fair Value Measurements
at December 30, 2023 Using
DescriptionQuoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable
Inputs
(Level 2)
Total
Cash equivalents:
Money market funds$137,195 $— $137,195 
Total cash equivalents$137,195 $— $137,195 
Short-term investments:
Corporate debt securities$— $130,047 $130,047 
Government debt securities— 81,673 81,673 
Total short-term investments$— $211,720 $211,720 
Total$137,195 $211,720 $348,915 
Valuation methodology
The Company’s cash equivalents and short-term investments that are classified as Level 2 are valued using non-binding market consensus prices that are corroborated with observable market data; quoted market prices for similar instruments in active markets; quoted prices in less active markets; or pricing models, such as a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data. The Company’s foreign currency derivative instruments are valued using discounted cash flow models. The assumptions used in preparing the valuation models include foreign exchange rates, forward and spot prices for currencies and market observable data of similar instruments.
The following summarizes the components of available-for-sale investments:
Reported As
As of March 30, 2024Amortized Cost BasisGross Unrealized GainsGross Unrealized LossesFair ValueCash EquivalentMarketable Securities
Corporate debt securities$59,107 $46 $(410)$58,743 $— $58,743 
Government debt securities82,685 19 (246)82,458 — 82,458 
Money market funds107,746 — — 107,746 107,746 — 
Total$249,538 $65 $(656)$248,947 $107,746 $141,201 
Reported As
As of December 30, 2023Amortized Cost BasisGross Unrealized GainsGross Unrealized LossesFair ValueCash EquivalentMarketable Securities
Corporate debt securities$130,858 $69 $(880)$130,047 $— $130,047 
Government debt securities82,091 137 (555)81,673 — 81,673 
Money market funds137,195 — — 137,195 137,195 — 
Total$350,144 $206 $(1,435)$348,915 $137,195 $211,720 
Contractual maturities of investments
The Company’s available-for-sale investments are reported at fair value, with unrealized gains and losses, net of tax, recorded as a component of accumulated other comprehensive loss in the Condensed Consolidated Balance Sheet. The following summarizes the contractual underlying maturities of the Company’s available-for-sale investments at March 30, 2024 (in thousands):
CostFair Value
Due in one year or less $112,498 $112,010 
Due after one year through five years 29,294 29,191 
$141,792 $141,201 
Unrealized Gains and Losses
The available-for-sale investments that were in a continuous unrealized loss position, aggregated by length of time that individual securities have been in a continuous loss position, were as follows (in thousands):
Less Than 12 Months12 Months or GreaterTotal
As of March 30, 2024Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
Corporate debt securities $2,501 $(1)$30,323 $(410)$32,824 $(411)
Government debt securities36,642 (166)30,174 (79)66,816 (245)
$39,143 $(167)$60,497 $(489)$99,640 $(656)
Less Than 12 Months12 Months or GreaterTotal
As of December 30, 2023Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
Corporate debt securities $12,449 $(13)$95,760 $(867)$108,209 $(880)
Government debt securities28,255 (115)31,122 (440)59,377 (555)
$40,704 $(128)$126,882 $(1,307)$167,586 $(1,435)
The gross unrealized losses as of March 30, 2024 and December 30, 2023 were due primarily to changes in market interest rates. At March 30, 2024 and December 30, 2023, there were no material unrealized gains associated with the Company’s available-for-sale investments.
The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors. When evaluating an investment for impairment, the Company reviews factors such as the severity of the impairment, changes in underlying credit ratings, forecasted recovery, the Company’s intent to sell or the likelihood that it would be required to sell the investment before its anticipated recovery in market value and the probability that the scheduled cash payments will continue to be made. As of March 30, 2024, there were no material declines in the market value of available-for-sale investments due to credit-related factors.
Fair values of other financial instruments
The Company’s other financial instruments, including cash, accounts receivable and accounts payable, are recorded at amounts that approximate their fair values due to their short maturities.